Skip to content
CancerIndex

Publication

Recurrent genetic fusions redefine MLL germ line acute lymphoblastic leukemia in infants.

Authors not recorded

Blood2021PMID 33512459stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (2)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 2

Curated evidence

Evidence citing this paper (1)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
33512459
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–1 of 1 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
NUTM1 Fusion1
(diagnostic)B-lymphoblastic Leukemia With NUTM1 RearrangementUNRESOLVEDDiagnosticBSupports Positive4accepted
EID12239

This 2021 study highlights the diagnostic significance of NUTM1 rearrangements in infants with B lymphoblastic leukemia (B-ALL) negative for KMT2A rearrangements. Among the 30 analyzed cases of KMT2A-… (full text at CIViC)

PMID 33512459 · Fazio et al., 2021 · Open in CIViC

civic